HK$15.67
1.95%
Hong Kong, Oct 21, 04:08 pm HKT. Closed.
ISIN
CNE100000FN7
Symbol
1099
Index

Sinopharm Group Stock price

HK$15.67
+0.56 3.71% 1M
-4.61 22.73% 6M
-3.77 19.39% YTD
-3.05 16.29% 1Y
-4.01 20.38% 3Y
-5.68 26.60% 5Y
-21.58 57.93% 10Y
-2.89 15.57% 20Y
Hong Kong, Closing price Wed, Oct 21 2026
+0.30 1.95%
ISIN
CNE100000FN7
Symbol
1099
Index

Is Sinopharm Group a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,102 stocks worldwide.

Key metrics

Basic
Market capitalization
HK$49.1b
Enterprise Value
HK$108.1b
Net debt
HK$59.1b
Cash
HK$36.5b
Shares outstanding
3.1b
Valuation
P/E
5.8
P/S | estimate
0.1 | 0.1
EV/Sales | estimate
0.2 | 0.2
EV/FCF | ex SBC
- | -
P/B
0.5
Dividends
DPS
HK$0.79
Yield 1Y | 5Y
5.1% | 4.3%
Growth 1Y | 5Y
6.9% | -1.2%
Payout 1Y | 3Y
29.4% | 28.4%
Increased
1 Year
Financials
Revenue | estimate
HK$672.1b | HK$700.4b
EBITDA
-
EBIT
HK$21.0b
Net Income
HK$8.3b
Free Cash Flow | ex SBC
- | -
Growth
Revenue | estimate
-0.7% | 3.6%
EBITDA
-
EBIT
4.6%
Net Income
4.1%
Free Cash Flow
-
Margin
Gross
7.1%
EBITDA
-
EBIT
3.1%
Net
1.2%
Free Cash Flow | ex SBC
- | -
Financial Health
Equity Ratio
21.5%
Return on Equity
8.5%
ROCE
12.2%
ROIC
6.2%
Debt/Equity
1.0
More
EPS
HK$2.7
FCF per Share
-
Short interest
-
Employees
95k
Rev per Employee
HK$7.1m

Sinopharm Group Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a Sinopharm Group forecast:

14x Buy
67%
7x Hold
33%

Analyst Opinions

21 Analysts have issued a Sinopharm Group forecast:

Buy
67%
Hold
33%

Sinopharm Group Events

Upcoming Event
OCT
23
Q3 2026 Earnings Call
in 2 days
View Past Earnings Reaction

Financial data from Sinopharm Group

Jun '26
+/-
%
672,107 672,107
1% 1%
100%
- Direct Costs 624,634 624,634
0% 0%
93%
47,473 47,473
5% 5%
7%
- Selling and Administrative Expenses 26,928 26,928
12% 12%
4%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 20,986 20,986
5% 5%
3%
Net Profit 8,336 8,336
4% 4%
1%

In millions HKD.

Don't miss a Thing! We will send you all news about Sinopharm Group directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. It operates through the following business segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers and other suppliers. The Medical Devices segment consists of the distribution of medical devices in China. The Retail Pharmacy segment refers to the network of retail drug stores in major cities of China via direct operations and franchises. The Other Business segment comprises of the production and sale of pharmaceutical products, chemical reagents and laboratory supplies. The company was founded on January 8, 2003 and is headquartered in Shanghai, China.

Head office China
Employees 94,910
Founded 2003
Website www.sinopharmgroup.com.cn

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today